388 related articles for article (PubMed ID: 12766053)
1. In vivo antiviral efficacy of a dipeptide acyclovir prodrug, val-val-acyclovir, against HSV-1 epithelial and stromal keratitis in the rabbit eye model.
Anand BS; Hill JM; Dey S; Maruyama K; Bhattacharjee PS; Myles ME; Nashed YE; Mitra AK
Invest Ophthalmol Vis Sci; 2003 Jun; 44(6):2529-34. PubMed ID: 12766053
[TBL] [Abstract][Full Text] [Related]
2. Novel dipeptide prodrugs of acyclovir for ocular herpes infections: Bioreversion, antiviral activity and transport across rabbit cornea.
Anand B; Nashed Y; Mitra A
Curr Eye Res; 2003; 26(3-4):151-63. PubMed ID: 12815543
[TBL] [Abstract][Full Text] [Related]
3. Dipeptide monoester ganciclovir prodrugs for treating HSV-1-induced corneal epithelial and stromal keratitis: in vitro and in vivo evaluations.
Majumdar S; Nashed YE; Patel K; Jain R; Itahashi M; Neumann DM; Hill JM; Mitra AK
J Ocul Pharmacol Ther; 2005 Dec; 21(6):463-74. PubMed ID: 16386088
[TBL] [Abstract][Full Text] [Related]
4. Ocular pharmacokinetics of acyclovir amino acid ester prodrugs in the anterior chamber: evaluation of their utility in treating ocular HSV infections.
Katragadda S; Gunda S; Hariharan S; Mitra AK
Int J Pharm; 2008 Jul; 359(1-2):15-24. PubMed ID: 18472234
[TBL] [Abstract][Full Text] [Related]
5. Effects of antiviral medications on herpetic epithelial keratitis in mice.
Komoto S; Higaki S; Fukuda M; Shimomura Y
Jpn J Ophthalmol; 2015 May; 59(3):194-200. PubMed ID: 25707352
[TBL] [Abstract][Full Text] [Related]
6. In vivo ocular pharmacokinetics of acyclovir dipeptide ester prodrugs by microdialysis in rabbits.
Anand BS; Katragadda S; Gunda S; Mitra AK
Mol Pharm; 2006; 3(4):431-40. PubMed ID: 16889437
[TBL] [Abstract][Full Text] [Related]
7. Comparative antiviral efficacies of cidofovir, trifluridine, and acyclovir in the HSV-1 rabbit keratitis model.
Romanowski EG; Bartels SP; Gordon YJ
Invest Ophthalmol Vis Sci; 1999 Feb; 40(2):378-84. PubMed ID: 9950596
[TBL] [Abstract][Full Text] [Related]
8. Effects of anti herpetic drugs on mice with herpetic epithelial keratitis after reactivation of herpes simplex virus type 1.
Itahashi M; Higaki S; Shimomura Y
Semin Ophthalmol; 2008; 23(4):241-7. PubMed ID: 18584562
[TBL] [Abstract][Full Text] [Related]
9. Effect of oral valaciclovir on herpetic keratitis.
Higaki S; Itahashi M; Deai T; Fukuda M; Shimomura Y
Cornea; 2006 Dec; 25(10 Suppl 1):S64-7. PubMed ID: 17001196
[TBL] [Abstract][Full Text] [Related]
10. Oral acyclovir for herpes simplex virus eye disease: effect on prevention of epithelial keratitis and stromal keratitis. Herpetic Eye Disease Study Group.
Arch Ophthalmol; 2000 Aug; 118(8):1030-6. PubMed ID: 10922194
[TBL] [Abstract][Full Text] [Related]
11. [Herpes simplex virus latency, reactivation, and a new antiviral therapy for herpetic keratitis].
Shimomura Y
Nippon Ganka Gakkai Zasshi; 2008 Mar; 112(3):247-64; discussion 265. PubMed ID: 18411713
[TBL] [Abstract][Full Text] [Related]
12. Effect of acylation on the ocular disposition of acyclovir. II: Corneal permeability and anti-HSV 1 activity of 2'-esters in rabbit epithelial keratitis.
Hughes PM; Mitra AK
J Ocul Pharmacol; 1993; 9(4):299-309. PubMed ID: 8106836
[TBL] [Abstract][Full Text] [Related]
13. Herpes simplex virus keratitis in children.
Chong EM; Wilhelmus KR; Matoba AY; Jones DB; Coats DK; Paysse EA
Am J Ophthalmol; 2004 Sep; 138(3):474-5. PubMed ID: 15364233
[TBL] [Abstract][Full Text] [Related]
14. Amino acid prodrugs of acyclovir as possible antiviral agents against ocular HSV-1 infections: interactions with the neutral and cationic amino acid transporter on the corneal epithelium.
Anand BS; Katragadda S; Nashed YE; Mitra AK
Curr Eye Res; 2004; 29(2-3):153-66. PubMed ID: 15512962
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of cobalt chelates in the rabbit eye model for epithelial herpetic keratitis.
Asbell PA; Epstein SP; Wallace JA; Epstein D; Stewart CC; Burger RM
Cornea; 1998 Sep; 17(5):550-7. PubMed ID: 9756451
[TBL] [Abstract][Full Text] [Related]
16. Predictors of recurrent herpes simplex virus keratitis. Herpetic Eye Disease Study Group.
Cornea; 2001 Mar; 20(2):123-8. PubMed ID: 11248812
[TBL] [Abstract][Full Text] [Related]
17. Clinical characteristics of acyclovir-resistant herpetic keratitis and experimental studies of isolates.
Yao YF; Inoue Y; Kase T; Uchihori Y; Mori Y; Ohashi Y
Graefes Arch Clin Exp Ophthalmol; 1996 Aug; 234 Suppl 1():S126-32. PubMed ID: 8871163
[TBL] [Abstract][Full Text] [Related]
18. The antimicrobial agent C31G is effective for therapy for HSV-1 ocular keratitis in the rabbit eye model.
Hill JM; Stern EM; Bhattacharjee PS; Malamud D; Clement C; Rodriguez P; Lukiw WJ; Ochoa AC; Foster TP; Velasco C; McFerrin HE
Antiviral Res; 2013 Oct; 100(1):14-9. PubMed ID: 23860013
[TBL] [Abstract][Full Text] [Related]
19. Oral acyclovir suppresses recurrent epithelial and stromal herpes simplex.
Langston DP
Arch Ophthalmol; 1999 Mar; 117(3):391-2. PubMed ID: 10088820
[No Abstract] [Full Text] [Related]
20. Valacyclovir inhibition of recovery of ocular herpes simplex virus type 1 after experimental reactivation by laser in situ keratomileusis.
Dhaliwal DK; Romanowski EG; Yates KA; Hu D; Mah FS; Fish DN; Gordon YJ
J Cataract Refract Surg; 2001 Aug; 27(8):1288-93. PubMed ID: 11524202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
